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A20 controls intestinal homeostasis
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The transcription factor NF-kB is indispensable for intestinal immune homeostasis, but
contributes to chronic inflammation and inflammatory bowel disease (IBD). A20, an
inhibitor of both NF-kB and apoptotic signalling, was identified as a susceptibility gene for
multiple inflammatory diseases, including IBD. Despite absence of spontaneous intestinal
inflammation in intestinal epithelial cell (IEC) specific A20 knockout mice, we found
additional myeloid-specific A20 deletion to synergistically drive intestinal pathology
through cell-specific mechanisms. A20 ensures intestinal barrier stability by preventing
cytokine-induced IEC apoptosis, while A20 prevents excessive cytokine production in myeloid
cells. Combining IEC and myeloid A20 deletion induces ileitis and severe colitis, characterized
by IEC apoptosis, Paneth and goblet cell loss, epithelial hyperproliferation and intestinal
microbiota dysbiosis. Continuous epithelial cell death and regeneration in an inflammatory
environment sensitizes cells for neoplastic transformation and the development of colorectal
tumours in aged mice.
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I
nflammatory bowel disease (IBD) is a chronic inflammatory
disorder of the gastrointestinal tract and includes Crohn’s
disease (CD) and ulcerative colitis (UC) as the main
phenotypes. The aetiology of IBD is complex and involves
interactions between genetic factors, environmental triggers
including the intestinal microbiota and the host immune
system. It is generally acknowledged that IBD arises as a result
of the loss of tolerance towards the normal intestinal microbiota
due to a hyperactive immune response and/or an instable
mucosal barrier1. One of the consequences of chronic intestinal
inflammation is the promotion of tumorigenesis, and patients
with IBD have a higher risk of developing colitis-associated
cancer (CAC)2. Genome-wide association studies and
immunochip analysis have up to now identified 163 IBD-
associated loci, many of them involved in immune regulation and
epithelial barrier function, including the NF-kB inhibitory
protein A20 (also known as TNFAIP3)3–6.
The transcription factor NF-kB has crucial roles in intestinal
homeostasis and pathology. On one hand, NF-kB contributes to
IBD development as a mediator of pro-inflammatory responses,
predominantly in the myeloid cells. On the other hand, NF-kB
activity in epithelial cells has a protective role through the
expression of anti-apoptotic proteins, antimicrobial peptides and
mucus, thus enhancing the epithelial barrier function7. An
important protective factor in the intestinal epithelium is the
NF-kB-inducible protein A20. Mice with enterocyte-specific A20
deletion (A20IEC-KO) are hypersensitive to dextran sodium
sulphate-induced colitis and to tumour necrosis factor (TNF)-
induced epithelial apoptosis and lethality8. Although A20 is
indispensable to maintain barrier integrity in conditions of
inflammation, A20IEC-KO mice do not spontaneously develop
intestinal inflammation8. Similarly, although mice with myeloid
cell-specific deletion of A20 (A20myel-KO) develop rheumatoid
arthritis-like symptoms due to excessive NF-kB activation and
inflammatory responses, they do not develop spontaneous
intestinal pathology9. The absence of any spontaneously
developing intestinal phenotype in A20IEC-KO or A20myel-KO
may therefore question the role of A20 in human IBD as
originally suggested by human genetic studies4–6. However, we
here show that spontaneous intestinal pathology develops when
mice are deficient for A20 in both intestinal epithelial cells (IECs)
and myeloid cells. A20IEC/myel-KO mice not only produce
high levels of inflammatory cytokines, but also develop
spontaneous intestinal inflammation characterized by increased
epithelial apoptosis and hyperproliferation. A20IEC/myel-KO
mice progressively lose their Paneth and goblet cells leading
to defective antimicrobial peptide and mucus production,
bacterial infiltration and severe colitis in aged mice. Over time,
A20IEC/myel-KO mice develop hyperplastic and dysplastic
epithelium which displays typical hallmarks of human
colorectal cancer, including hyperactive Wnt signalling and
aberrant stem cell marker expression.
Results
A20IEC/myel-KO mice develop spontaneous intestinal defects.
We have previously shown that A20IEC-KO mice do not show any
spontaneous phenotype but are hypersensitive to experimental
colitis associated with increased IEC apoptosis8. In contrast,
A20myel-KO mice develop rheumatoid arthritis-like symptoms,
but not colitis, due to hyperactivated myeloid cells producing
elevated levels of inflammatory cytokines, including TNF and
interleukin-6 (IL-6) (ref. 9). Combined IEC and myeloid A20
deficiency (A20IEC/myel-KO) fully recapitulates the inflammatory
phenotype of A20myel-KO mice, showing myeloid cell expansion
with lymphadenopathy and splenomegaly, and increased levels of
TNF and IL-6 in their serum (Supplementary Fig. 1). In
contrast to wild-type control, A20myel-KO and A20IEC-KO mice,
A20IEC/myel-KO mice spontaneously develop colitis symptoms, as
revealed by histological and stool colitis scoring (Fig. 1a).
Intestinal inflammation is rather mild in young A20IEC/myel-KO
mice but progresses to ileitis and moderately active chronic colitis
in aged mice (Supplementary Fig. 2). Histological analysis of
distal ileal segments showed severe depletion of granular Paneth
cells in crypts of A20IEC/myel-KO mice in contrast to crypts of
wild-type mice, as revealed by Alcian-blue-PAS (AB-PAS)
staining (Fig. 1b) or immunostaining for lysozyme (Fig. 1c). In
addition, in situ hybridization of Paneth cell-specific cryptidine-1
(Crypt-1) on ileal sections shows strong and homogeneous
Crypt-1 expression in wild-type mice, while Crypt-1 expression is
compromised in crypts of A20IEC/myel-KO mice (Fig. 1d).
Expression analysis of Paneth cell-specific Crypt-1 and
lysozyme-P (LysP) by quantitative PCR on ileal epithelial cell
lysates shows dramatically reduced expression levels in
A20IEC/myel-KO mice compared with wild-type controls
(Fig. 1e). Next to Paneth cell defects, A20IEC/myel-KO mice also
display substantially reduced numbers of mucus-producing goblet
cells. Carnoy fixed colon samples from wild-type, A20IEC-KO,
A20myel-KO and A20IEC/myel-KO mice were used for Muc-2
immunostaining and bacterial 16S FISH10 to visualize the
bacterial epithelial interface. Intestinal bacteria are separated
from the epithelium by a sterile mucous layer of approximately
40 mm thick in wild-type, A20IEC-KO and A20myel-KO mice,
whereas in A20IEC/myel-KO mice the mucous layer is significantly
thinner and often interrupted, allowing closer interaction between
bacteria and epithelial cells (Fig. 1f,g). In agreement, the
expression of goblet cell-specific Muc-2 expression is
significantly reduced, as shown by quantitative PCR on colon
samples from A20IEC/myel-KO mice (Fig. 1h). Together, these data
demonstrate the spontaneous development of intestinal
inflammation and epithelial defects, including early loss of
Paneth and goblet cells in A20IEC/myel-KO mice.
IEC apoptosis and hyperproliferation in A20IEC/myel-KO mice.
Tissue analysis by transmission electron microscopy of ileal
crypts from wild-type mice shows Paneth cells containing
large intracellular vacuoles alternated by intestinal stem cells
(Fig. 2a). Ileal crypts of A20IEC/myel-KO mice, however, are devoid
of granular Paneth cells, and individual stem cells cannot be
identified on the basis of morphology only (Fig. 2a). In addition,
crypt regions of A20IEC/myel-KO mice contain phagocytosed dead
cell fragments, which stain positive for TUNEL and cleaved
caspase-3 indicating that A20IEC/myel-KO crypt cells undergo
apoptosis (Fig. 2b,c). Quantification of active caspase-3 positive
cells reveals significantly increased numbers of apoptotic cells in
both ileum and colon of A20IEC/myel-KO mice (Fig. 2d).
Next, epithelial cell proliferation was determined by Ki67
immunohistochemistry. Slow cycling stem cells, which are only
sporadically Ki67þ , are positioned at the crypt bottom and give
rise to active cycling (high Ki67þ ) transit amplifying cells which
are located above the stem cell/Paneth cell compartment in the
small intestine of wild-type mice (Fig. 2e)11. In A20IEC/myel-KO
mice, however, proliferating (Ki67þ ) active cycling cells occupy
the entire crypts including the crypt bottoms (Fig. 2e). Since
Paneth cells support intestinal stem cells by producing trophic
factors12, we wondered if Paneth cell loss had a direct impact on
the stem cell compartment. In situ hybridization for the small
intestinal stem cell marker olfactomedin-4 (Olfm4) shows
comparable Olfm4 expression in the crypts of A20IEC/myel-KO
mice compared with crypts from wild-type mice (Fig. 2f),
indicating that the stem cell compartment is not affected in
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6103
2 NATURE COMMUNICATIONS | 5:5103 | DOI: 10.1038/ncomms6103 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
A20IEC/myel-KO mice. In addition, changes in expression of
intestinal stem cell markers could not be observed in the
small intestine of A20IEC/myel-KO mice compared with wild-type
mice (Supplementary Fig. 3). Together, these data show
that Paneth cell deficiency does not affect normal stem cell
numbers and suggest redundant mechanisms for stem cell
support in the small intestine of A20IEC/myel-KO mice. Similar
to our observations in the small intestine, increased apoptosis
in the colon (Fig. 2b–d) is accompanied by increased
cell proliferation as shown by Ki67 immunohistochemistry
(Fig. 2e). While cell proliferation is confined to the colonic
crypt bottom in wild-type mice, proliferating cells in
A20IEC/myel-KO mice populate almost the entire elongated
crypts (Fig. 2e). In conclusion, A20IEC/myel-KO mice display
increased IEC apoptosis and proliferation in both the small and
large intestine.
A20-deficient Paneth cells undergo cytokine-induced apoptosis.
Wnt signalling is essential for Paneth cell maturation13–15
suggesting that disturbed Wnt signalling might contribute to
reduced Paneth cell numbers in A20IEC/myel-KO mice. Although
A20 has recently been suggested to restrict Wnt signalling in the
intestinal epithelium by binding to the b-catenin destruction
complex supporting b-catenin ubiquitination and degradation16,
normal b-catenin and Sox9 expression is observed on sections from
small intestinal tissue from A20IEC/myel-KO mice (Supplementary
Fig. 4a,b). In addition, wild-type and A20-deficient organoids
stimulated with Wnt3a for 6 h show similar expression of Wnt
target genes Cyclin-D1 and c-Myc (Supplementary Fig. 4c).
Together these data indicate that A20 deficiency does not affect
Wnt signalling and gene expression in vitro and in vivo.
To assess whether A20IEC/myel-KO mice have inherent crypt
defects or develop these defects progressively, ileal sections from
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Figure 1 | A20IEC/myel-KO mice develop spontaneous intestinal defects. (a) Clinical colitis scores on the basis of histological (hist., upper graph)
and stool (lower graph) colitis parameters of naive 10–30-week-old A20IEC-KO (hist. score n¼ 8, stool score n¼ 12), A20myel-KO mice (hist. score n¼ 8,
stool score n¼ 16), A20IEC/myel-KO mice (hist. score n¼ 8, stool score n¼ 18) and control wild-type (WT) littermate mice (hist. score n¼8, stool score
n¼ 15). All A20IEC/myel-KO mice display colitis histopathology and mild stool colitis scores. (b) AB-PAS staining of ileal sections from 30-week-old
A20IEC/myel-KO and wild-type (WT) control littermates. The crypt base region with highly granular Paneth cells in WT section is indicated by square
brackets (Scale bars, 20mm). (c) Immunostaining of ileal sections using an antibody-recognizing lysozyme in intracellular granules of Paneth cells (Scale
bars, 20mm). (d) In situ hybridization on ileal sections using a specific probe recognizing Crypt-1 transcripts (Scale bars, upper: 150mm, lower: 50mm).
(e) Quantitative PCR analysis for LysP and Crypt-1 on IEC lysates from the small intestine from 12-week-old wild-type (WT, n¼ 5) and A20IEC/myel-KO
(n¼ 9) mice. (f) Immunofluorescent staining for Muc-2 and 16S bacterial FISH on colon sections from 20-week-old A20IEC-KO, A20myel-KO mice,
A20IEC/myel-KO and control wild-type (WT) littermate mice (Scale bars, 50mm). (g) Thickness of bacterium-free mucus layer of colon tissue of wild-type
(WT, n¼ 9), A20IEC-KO (n¼8), A20myel-KO (n¼ 10) and A20IEC/myel-KO mice (n¼9). (h) Quantitative PCR analysis for Muc-2 on IEC colon lysates
from 30-week-old wild-type (WT, n¼ 5) and A20IEC/myel-KO (n¼8) mice. Error bars represent s.e.m. *Po0.05, **Po0.01, ***Po0.001 using Student’s t-test.
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A20IEC/myel-KO mice of different age were analysed. In contrast to
5-week-old A20IEC/myel-KO mice, which have mature Crypt-1
expressing Paneth cells in the intestinal crypts, the number of
Paneth cells drastically drops around the age of 10 to 15 weeks
(Fig. 3a). In contrast to the reduction in Crypt-1 expression,
Olfm4 expression stays relatively stable in mice of different age
(Fig. 3b), indicating that Paneth cell loss does not strongly affect
intestinal stem cell populations. Immunohistochemical staining
for the Paneth cell marker lysozyme in combination with
TUNEL, identifying apoptotic cells, confirmed the impaired
survival of Paneth cells in A20IEC/myel-KO mice. While crypts of
5-week-old A20IEC/myel-KO mice do not show signs of apoptosis,
most crypts of older A20IEC/myel-KO mice display apoptotic cells,
often colocalizing with epithelial lysozyme, indicative of Paneth
cells (Fig. 3c). Twenty-week-old A20IEC/myel-KO mice have
severely reduced Paneth cell numbers in their crypts (Fig. 3c).
In agreement with the progressive loss of Paneth cells in A20IEC/
myel-KO mice, we observed an age-dependent reduction in
antimicrobial LysP and Crypt-1 peptide expression in the ileal
epithelial lysates (Fig. 3d). Interestingly, Paneth cell apoptosis
coincides with the mucosal accumulation of lysozyme-positive
myeloid cells (Fig. 3c), suggesting that cytokines released by
recruited A20-deficient myeloid cells may induce Paneth cell
apoptosis. In line with this, increasing amounts of the
inflammatory cytokines IL-6 and TNF could be measured in
serum from A20IEC/myel-KO mice of different age (Fig. 3e). The
hypersensitivity of A20-deficient Paneth cells to apoptosis could
be confirmed in A20IEC-KO mice exposed to TNF. Unchallenged
A20IEC-KO mice have a normal crypt architecture with normal
Paneth cell numbers8. When injecting a sublethal dose of
recombinant TNF, apoptosis of crypt cells including Paneth
cells can be observed (Supplementary Fig. 5a). Twenty four hours
after injection, Paneth cells are strongly reduced. In agreement,
quantification of LysP and Crypt-1 expression by quantitative
PCR shows strong reduction of both Paneth cell markers after
TNF exposure (Supplementary Fig. 5b). Finally, in vitro studies
on intestinal organoid cultures confirmed the above findings in
mice. Stimulation of organoid cultures derived from wild-type
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Figure 2 | IEC apoptosis and hyperproliferation in A20IEC/myel-KO mice. (a) Transmission electron micrographs of small intestinal crypt region of
wild-type (WT) and A20IEC/myel-KO mice. Arrows indicate condensed phagocytosed dead cell remnants (Scale bars, 4mm) (S¼ stem cell, P¼ Paneth cell).
(b,c) Representative TUNEL staining (b) and immunostaining of active caspase-3 (c) in crypts of the terminal ileum and colon of wild-type (WT),
A20IEC-KO, A20myel-KO and A20IEC/myel-KO mice (Scale bars, 50mm). (d) Quantification of cleaved caspase-3 positive cells in crypts of wild-type (WT,
n¼ 5), A20IEC-KO (n¼ 5), A20myel-KO (n¼ 5) and A20IEC/myel-KO mice (n¼ 5). Error bars represent s.e.m. ***Po0.001 using Student’s t-test.
(e) Ki67 immunostaining on wild-type (WT) and A20IEC/myel-KO ileal crypts (Scale bars, 5 mm). (f) In situ hybridization for Olfm4 on wild-type (WT) and
A20IEC/myel-KO ileal crypts using an Olfm4 specific probe (Scale bars, 5mm).
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and A20IEC-KO mice with recombinant TNF or IFNg, induces
complete disintegration of A20-deficient organoids, in contrast to
wild-type organoids which remain largely unaffected (Fig. 3f,
Supplementary Movies 1 and 2). Moreover, lysozyme
immunostaining for Paneth cells combined with TUNEL or
cleaved caspase-3, demonstrates Paneth cell apoptosis in A20-
deficient organoid cultures exposed to TNF (Fig. 3g and
Supplementary Fig. 6). Similar observations were done on
exposure of organoids to IFNg (Fig. 3g and Supplementary
Fig. 6). In conclusion, Paneth cells in A20IEC/myel-KO mice
undergo progressive cell death induced by cytotoxic cytokines
including TNF and IFNg.
Severe colitis and colorectal tumour development in aged
A20IEC/myel-KO mice. We have shown that A20IEC/myel-KO mice
have a compromised intestinal barrier due to epithelial apoptosis
and progressive Paneth and goblet cell loss, which facilitates
bacterial epithelial interaction and infiltration, likely further
enhancing local inflammation and IEC damage. Aged A20IEC/
myel-KO mice (30-week and older) develop severe inflammation as
evidenced by the thickening of the bowel wall (Fig. 4a and
Supplementary Fig. 2). On AB-PAS-stained A20IEC/myel-KO colon
sections, severe elongation of hyperproliferative Ki67þ crypts,
lacking nearly all goblet cells, can be observed (Fig. 4a,b). CD45
immunostaining shows severe immune cell infiltration in colonic
sections of A20IEC/myel-KO mice (Fig. 4c). In line with previous
observations in young A20IEC/myel-KO mice (Fig. 2e), aged
A20IEC/myel-KO mice show pronounced epithelial apoptosis in
colon tissue (Fig. 4d). Goblet cell loss, reduced mucin production
and increased epithelial apoptosis severely affect the intestinal
barrier, which compromises the spatial segregation of bacteria
from the epithelial surface and even allows bacterial mucosal
infiltration in A20IEC/myel-KO mice (Fig. 4e). High-resolution
endoscopy shows a granular and bleeding mucosal surface indi-
cative of colitis in A20IEC/myel-KO mice, in contrast to wild-type,
A20IEC-KO and A20myel-KO mice, which display a healthy
mucosal surface with normal vessel architecture (Fig. 4f,g).
Finally, histological colitis scores, which were shown to be
increased in young A20IEC/myel-KO mice (Fig. 1a), increase to
much higher levels in older (430 weeks old) A20IEC/myel-KO
mice (Fig. 4h).
O
lfm
4
Ly
so
zy
m
e/
Tu
ne
l/D
AP
I
5 Weeks 10 Weeks 15 Weeks 20 Weeks
W
T
TNF
Age (weeks) Age (weeks)
Age (weeks)Age (weeks)
20
15
10
0
5
10 15 21 24 34 38
5 10 15 21 24 34 38
5 10 15 520
5 10 15 20
15
10
0
5
TN
F 
pg
 m
l–1
IL
-6
 p
g 
m
l–1
R
el
at
iv
e 
Ly
sP
 e
xp
re
ss
io
n
R
el
at
iv
e 
Cr
yp
t-1
 e
xp
re
ss
io
n
0
20
30
10
40
50
0
200
300
100
400
500
WT
A20IEC/myel-KO WT
A20IEC/myel-KO
WT
A20IEC/myel-KO
WT
A20IEC/myel-KO
Cr
yp
t-1
Control TNF IFNγ
A2
0–
/–
W
T
A2
0–
/–
Lysozyme/TUNEL/DAPI
IFNγControl
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(e) Levels of IL-6 and TNF in serum from wild-type (WT) and A20IEC/myel-KO mice of different age. (f) Representative pictures of wild-type (WT) and
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Strikingly, A20IEC/myel-KO mice older than 30 weeks of age
often display tumour-like lesions in their colon (43%, n¼ 44;
Fig. 5a). Indeed, endoscopic examination reveals multiple
adenomatous polyps in old A20IEC/myel-KO mice (Fig. 5b).
Histological examination of affected regions shows a
severely inflamed colonic mucosa containing dysplastic crypts,
characterized by hyperproliferation, dysregulated crypt
shape and orientation, loss of cell differentiation and low scale
stratification (Fig. 5c). The tumours are however benign
adenomas and do not invade submucosal tissue. Epithelial cells
in these dysplastic tumour regions display elevated nuclear
b-catenin and Sox9 expression (Fig. 5d,e), indicative for
hyperactive Wnt signalling, and characteristic for colon adenoma
development17. In addition, dysplastic crypt areas express
Olfm4, which is a marker for murine small intestinal stem cells
and is normally not observed in colon tissue of healthy mice,
but is characteristic for human colon adenocarcinomas18
(Fig. 5f). Together, we hypothesize that severe colitis and
colorectal cancer development in aged A20IEC/myel-KO mice is
induced through continuous epithelial damage and regeneration,
driven by cytotoxic factors released by hyperactive A20-deficient
myeloid cells. We can however not exclude a contribution of
other infiltrating immune cells, like T cells, to this phenotype.
We therefore crossed A20IEC/myel-KO mice into a Rag2-deficient
background, generating mice also lacking functional T and B
cells. A20IEC/myel-KO Rag2 / mice, however, still display
spontaneous IEC apoptosis both in small intestine and
colon, similar to A20IEC/myel-KO Rag2þ / mice (Fig. 6a).
A20IEC/myel-KO Rag2 / mice also display small intestinal
crypt hyperproliferation, as shown by Ki67 staining (Fig. 6b).
In colon, A20IEC/myel-KO Rag2 / mice already show clear
signs of dysplasia, including misoriented star-shaped crypts, at an
early age (15 weeks) compared with A20IEC/myel-KO Rag2þ /
mice, which only display modest crypt hyperproliferation at this
age (Fig. 6b). Leukocyte anti-CD45 staining does not show
dramatic immune cell infiltration in ileal sections of 15-week-old
A20IEC/myel-KO Rag2þ / and A20IEC/myel-KO Rag2 / mice
(Fig. 6c, upper panel). In colon, however, immune cell staining is
strongest in A20IEC/myel-KORag2 / mice, where CD45þ cells
surround dysplastic crypt areas (Fig. 6c). In conclusion,
spontaneous intestinal defects observed in A20IEC/myel-KO mice
are preserved in Rag2-deficient conditions, indicating that
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(n¼ 5) and A20IEC/myel-KO (n¼ 8) mice. (h) Histological colitis scoring on aged wild-type (WT, n¼8), A20IEC-KO (n¼8), A20myel-KO (n¼ 8) and
A20IEC/myel-KO (n¼ 8) mice showing strong colitis only in A20IEC/myel-KO mice. Error bars represent s.e.m. ***Po0.001 using Student’s t-test.
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functional T and B cells are dispensable for the inflammatory
and tumorigenic phenotype of A20IEC/myel-KO mice. Even more,
A20IEC/myel-KORag2 / mice develop much earlier severe
colitis and dysplasia compared with A20IEC/myel-KORag2þ /
littermates, suggesting rather protective activities of T and B cells
in this context. Indeed, Rag2 / mice lack regulatory
T cells (Tregs) and IgA-producing plasma cells which perform
important immunoprotective functions in the intestine.
A20 deficiency influences gut microbial composition. Since the
intestinal microbiome has profound effects on the immune
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system19 and autoimmune pathologies including IBD are
associated with changes in the composition of the intestinal
microbiome20, we investigated to what extent bacterial
communities were altered in the different A20 knockout mice.
For this we performed 16S rDNA pyrosequencing analysis on
caecal content from cohoused littermate wild-type, A20IEC-KO,
A20myel-KO and A20IEC/myel-KO mice. Enterocyte-specific A20
deficiency had no impact on intestinal microbial richness and
composition (Fig. 7), in accordance with the absence of any
spontaneous phenotype in unchallenged A20IEC-KO mice8.
However, both A20myel-KO and A20IEC/myel-KO mice have
significantly lower intestinal microbial richness compared with
wild-type and A20IEC-KO mice (Fig. 7a, Supplementary Table 1).
Although A20myel-KO mice have no spontaneous intestinal
phenotype, the observed dysbiosis may be linked to the
rheumatoid arthritis-like phenotype of these mice9. Indeed,
studies have shown that the inflammatory status of the host is
inversely correlated to the richness of its microbial
communities21,22. We observed that wild-type and A20IEC-KO
mice have more similar gut communities than A20myel-KO and
A20IEC/myel-KO mice, suggesting the latter have less stable
microbiotas due to their inflammatory phenotype (Fig. 7b).
Nevertheless, A20IEC/myel-KO microbiotas are still significantly
different to those of A20myel-KO mice in terms of composition
(Fig. 7b,c; anosim P-value¼ 0.048) and only A20IEC/myel-KO mice
are significantly different from the wild-type microbiota when
taking into account bacterial phylogeny (Supplementary Table 2).
A20IEC/myel-KO mice have increased abundance of Deferribacteres
compared with the other three genotypes (Fig. 7c;
P-value¼ 0.009). Due to coprophagy, cage-effects can become
non-negligible confounders in mice microbiota analysis22
(Supplementary Table 3). After controlling for gender-, age-
and cage-effects, the Deferribacteres increase in A20IEC/myel-KO
mice is the only significant genotype-associated difference
(Fig. 7d, P-value¼ 0.041 after multiple testing correction). This
result is driven by a single-species assignment to Mucispirillum
schaedleri, known to colonize the mucus layer of the
gastrointestinal tract of rodents23. In this context, the
Mucispirillum genus can be regarded as a biomarker for
spontaneous colitis in A20IEC/myel-KO mice. It remains currently
unclear whether the observed dysbiosis solely develops in
response to inflammation or actively contributes to the onset,
maintenance and exacerbation of intestinal inflammation and
neoplastic transformation in A20IEC/myel-KO mice.
*
Bact
eroid
etes
Firm
icute
s
Phot
eoba
cteria
Defe
rriba
ctere
s
A2
0-
as
so
cia
te
d 
m
icr
ob
io
m
e 
va
ria
tio
n
(ce
ntr
ed
 an
d s
ca
led
 ab
u
n
da
nc
es
)
WT
1 2 3
Co
m
m
u
n
ity
 d
ist
an
ce
W
e
ig
ht
ed
 U
ni
Fr
a
c
Si
m
ila
r
D
iff
e
re
n
t
0
0.1
0.2
0.3
0.4
0.5
0.6
W: WT
Within genotype Between genotypes
+
* ***
E: A20IEC-KO
M: A20myel-KO
D: A20IEC/myel-KO
WT
A20IEC-KO
A20myel-KO
A20IEC/myel-KO
R
ic
hn
es
s 
(N
 ob
se
rve
d 
sp
ec
ie
s)
350
300
400
W E M D W/E W/M W/D M/D
GenotypeSample count
A20IEC-KO
A20IEC/myel-KO
65%
32%
1% 0.5%
2%
Bacteroidetes
Firmicutes
Proteobacteria
Deferribacteres
Other
62%
37%
59%
38%
1%
1%
66%
28%
4%
2%
A20myel-KO
0.10
0.05
0.00
–0.05
–0.10
W E M D
Genotype
W E M D W E M D W E M D
WT
A20IEC-KO
A20myel-KO
A20IEC/myel-KO
Figure 7 | A20 deficiency influences gut microbial composition. Microbiota analysis by 16S rDNA pyrosequencing of wild-type (WT), A20IEC-KO,
A20myel-KO and A20IEC/myel-KO mice: (a) Distribution of observed microbiota richness. (b) Average weighted UniFrac distance (distance between
communities on the basis of abundance and bacterial phylogenetics) within- and between-mouse genotypes. Anosim test with star phylogeny: *Po0.05,
**Po0.001. Anosim with bacterial phylogenetic tree:þPo0.05. (c) Phylum-level comparisons of compiled samples. (d) Phylum-level abundance variation
after controlling for cage-effects. Wilcoxon (BH correction). *Po0.05. W¼ WT, E¼A20IEC-KO, M¼A20myel-KO and D¼A20IEC/myel-KO.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6103
8 NATURE COMMUNICATIONS | 5:5103 | DOI: 10.1038/ncomms6103 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
A20 polymorphisms and expression levels in human IBD
patients. Multiple SNPs in the A20 locus have previously been
associated to inflammatory and autoimmune pathologies,
including IBD24,25. To confirm the association of genetic variants
in A20 to IBD, 17 of these SNPs were genotyped using Illumina
custom chip in a cohort of 2,400 IBD patients (847 with UC and
1,553 with CD) and allele frequencies were compared with 921
healthy controls. None of these SNPs, however, showed genome-
wide significance for association to IBD (Supplementary Table 4).
Strikingly, clear correlation between specific A20 polymorphisms
and primary therapeutic response to anti-TNF (infliximab)
therapy could be observed (Table 1). Association for response
to infliximab was seen with three intronic SNPs (rs6927210, rs
7753394, rs7773904), all in strong linkage disequilibrium
(r2¼ 0.99). The strongest association was observed between
carriers of the A allele of rs6927210 and response to
infliximab (Pcorr¼ 0.036, odds ratio¼ 1.335 (1.016–1.755)).
This association remained significant (logistic regression
analysis) after correction for disease (CD or UC) and disease
location. Haplotype analysis revealed that the rs6927210 G–
rs946227 G–rs7753394 A–rs7773904 C haplotype was associated
with non-response to infliximab (P¼ 0.007, odds ratio¼ 1.635
(1.140–2.345); Table 1). These data are in agreement with
observations in psoriasis patients, where two SNPs in the A20
locus were associated to responsiveness to anti-TNF therapy26.
Since the SNPs associated to infliximab responsiveness are
located in intronic sequences, they may affect regulatory elements
which interfere with A20 expression. We therefore analyzed
whether A20 expression in mucosal biopsies was linked to
primary infliximab responsiveness, as previously described27. In
colonic IBD, the mucosal expression of A20 was significantly
lower in responders versus non-responders before treatment
(Supplementary Fig. 7). After infliximab therapy, expression was
significantly downregulated in responders with complete mucosal
healing, but not in non-responders. (Supplementary Fig. 7). In
contrast, no significant differences in A20 ileal expression were
observed in CD patients with ileal disease (Supplementary Fig. 7),
but here sample size (n¼ 8) was lower than the sample size of the
colonic IBD group (n¼ 20). Taken together, analysis of human
patient samples identified A20 gene polymorphisms and mucosal
expression levels as good prognostic markers for primary
response to anti-TNF treatment.
Discussion
We hereby described a new mouse model of spontaneous
intestinal inflammation and CAC, and shed light on the
(patho)physiological importance of A20 in maintaining intestinal
immune homeostasis. The functions of A20 are diverse and cell
type-dependent: myeloid cells require A20 to prevent their
spontaneous hyperactivation and expansion9, while IECs need
A20 as a protective factor maintaining barrier stability in
inflammatory conditions8. Although single IEC or myeloid
deletion does not cause spontaneous intestinal defects, double
IEC and myeloid A20 deficiency induces spontaneous intestinal
pathology due to hyperinflammatory A20-deficient myeloid cells
causing epithelial apoptosis and progressive loss of Paneth and
goblet cells. Evidently, barrier destabilization caused by epithelial
apoptosis combined with defective antimicrobial peptide and
mucus production allows bacterial infiltration leading to more
inflammation and damage to the epithelium (Supplementary
Fig. 8). This self-perpetuating condition causes severe
inflammation and is strongest at sites with highest bacterial
density, viz. in the colon, underscoring the involvement of
infiltrating intestinal bacteria in the inflammatory pathology.
These data thus identify A20 as the major anti-apoptotic protein
indispensable for intestinal epithelial barrier stability and IEC
survival during inflammation.
Secretion of antimicrobial peptides by Paneth cells is an
important protective mechanism by which intestinal immune
homeostasis is established28,29, and defects in Paneth cell function
have been described in IBD patients30,31 and in multiple mouse
lines, which develop spontaneous intestinal inflammation, such as
Casp8IEC-KO (ref. 32), FADDIEC-KO (ref. 33), NEMOIEC-KO
(ref. 34) and IKK2caIEC mice35. In addition, mice defective in
ER stress signalling or autophagy, such as XBP1IEC-KO mice36
and hypomorphic ATG16L1 mice37, respectively, display Paneth
cell abnormalities. Moreover, intestinal inflammation may even
emerge from malfunctioning Paneth cells38. A20 deficiency in
IECs does not cause spontaneous Paneth cell defects, but
sensitizes their apoptotic loss in inflammatory conditions, either
by direct low-dose TNF exposure or by exposure to cytokines
produced by hyperactive A20-deficient myeloid cells, including
TNF and IFNg. Both these cytokines are well known for their
cytotoxic activities on IECs and may contribute to the
development of intestinal inflammation through their direct
activity on Paneth cells39–41. Also goblet cells are severely affected
in A20IEC/myel-KO mice, compromising the protective epithelial
mucus layer. Goblet cell depletion is also a frequent
histopathological feature of IBD42,43, and goblet cells are also,
due to their secretory character, highly sensitive to ER stress and
inflammatory cytokines36. The early loss of Paneth and goblet
cells in A20IEC/myel-KO mice and subsequent reduction in innate
defence may thus sensitize these mice to the development of
intestinal inflammation.
CAC is the most serious complication of IBD, and it is now
well accepted that chronic inflammation drives neoplastic
transformation of the intestinal epithelium2,44. NF-kB
activation in IECs may promote CAC development by driving
the expression of pro-survival genes, and growth factors creating
a tumour-promoting microenvironment35,45,46. Moreover, NF-
kB can enhance Wnt activation and induce dedifferentiation of
Table 1 | Polymorphisms associated with primary response to infliximab in IBD patients (n¼834).
SNP Chr Position* Risk allele Other allele RAF Test of association
OR 95% CI Pw Pz Py
rs6927210 6 138117846 A G 0.51 1.34 1.02–1.76 3.57E02 4.47E02 3.79E02
rs7753394 6 138126941 G A 0.51 1.33 1.01–1.75 3.77E02 4.66E02 3.93E02
rs7773904 6 138127058 A C 0.51 1.34 1.01–1.77 4.17E02 4.84E02 4.32E02
Chr, chromosome; CI, confidence interval; IBD, inflammatory bowel disease; OR, odds ratio; RAF, risk allele frequency; SNP, single-nucleotide polymorphism. All three SNPs are in strong linkage
disequilibrium (r2¼0,99). Risk allele corresponds with primary response.
*Build NCBI36.
wUsing the Cochran-Armitage trend test.
zAdjusted for disease.
yAdjusted for disease location.
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non-stem cells that acquire tumour-initiating capacity47,
therefore chronic NF-kB activation can bypass the requirement
of Wnt activating mutations during early CAC development. In
addition, ROS production and NF-kB signalling facilitate Wnt-
driven stem-cell proliferation and transformation initiating colon
cancer development48. A20IEC/myel-KO mice develop colorectal
adenomas with dysplastic regions characterized by increased
expression of b-catenin and Sox9, indicative of a hyperactive Wnt
signalling, and by the expression of the intestinal stem cell marker
Olfm4, which is characteristic for a subset of human colorectal
cancers18. A recent study reported a role for A20 in restricting
Wnt signalling suppressing colorectal cancer development16. Our
data, however, do not suggest a direct role for A20 in Wnt
inhibition, since we did not observe enhanced Wnt activation in
IECs from A20IEC-KO mice or in tumour-free areas from A20IEC/
myel-KO mice. We therefore believe that aberrant Wnt activation
in dysplastic crypt foci is caused by secondary events due to
chronic inflammation. Finally, T and B cells are dispensable for
the development of intestinal inflammation and dysplasia in
A20IEC/myel-KO mice. A20IEC/myel-KO Rag2 / mice develop an
even more severe and earlier intestinal inflammation and
dysplasia compared with A20IEC/myel-KO mice, indicating
protective functions for the adaptive immune system in this
model. In this respect, A20IEC/myel-KO Rag2 / mice resemble
TRUC (Tbet- and Rag2-deficient UC) mice, which develop severe
colitis and CAC induced by hyperactive dendritic cells and innate
lymphoid cells in the absence of protective T and B cell
responses49–51.
To translate the above described findings to humans, samples
from a large cohort of IBD patients were analyzed. Indeed,
A20 polymorphisms have been associated to multiple inflamma-
tory pathologies including IBD24,25. Although none of the
published A20 SNPs showed genome-wide significance for
susceptibility to IBD, we found specific haplotypes to be
associated with non-response to infliximab. In addition, lower
expression levels of A20 seem predictive of primary response to
infliximab, while non-responders display significantly higher and
stable A20 expression levels. These data are in line with studies in
rheumatoid arthritis patients52 and Crohn’s disease patients53
where low A20 expression has been correlated to good anti-TNF
response. Taken together, we identified A20 as a potential
biomarker for the prognosis of anti-TNF therapy. Since 10–20%
of IBD patients fail to respond to initial anti-TNF treatment, early
identification of non-responsive patients is of great medical and
socioeconomic value.
Methods
Generation of tissue-specific A20-deficient mice. Conditional A20/tnfaip3
knockout mice, in which exons IV and V of tnfaip3 gene are flanked by two LoxP
sites, were previously described8. A20 floxed (A20FL/FL) mice were crossed with
LysM-Cre transgenic mice54 generating myeloid-specific A20 knockout mice
(A20myel-KO, A20FL/FL LysMCreTg/þ ), or with Villin-Cre transgenic mice55
generating IEC-specific A20 knockout mice (A20IEC-KO, A20FL/FL VillinCreTg/þ ).
A20myel-KO and A20IEC-KO mice were intercrossed generating mice lacking A20
both in myeloid cells and IECs (A20IEC/myel-KO, A20FL/FL VillinCreTg/þ
LysMCreTg/þ ). As wild-type (WT) controls, A20 floxed (A20FL/FL VillinCreþ /þ
LysMCreþ /þ ) sex-matched littermate mice were used in all studies. Experiments
were performed on both male and female mice backcrossed into the C57BL/6
genetic background for at least four generations. Mice were housed in individually
ventilated cages in a specific pathogen-free facility. All experiments on mice were
conducted according to institutional, national and European animal regulations.
Animal protocols were approved by the ethics committee of Ghent University.
Histological colitis score. Histopathology was scored as described earlier56.
Briefly, colitis scores were determined as averages of six histological parameters
(goblet cell loss, crypt abscesses, mucosal hyperaemia, cellular infiltration in the
lamina propria, mucosal elongation and epithelial erosion), with scores according
to a scale as follows: 0, normal histology; 1, mild pathology for each histological
parameter; 2, moderate pathology; and 3, severe pathology. Histological scores of
the proximal, middle and distal portion of the colons were determined, and the
average was calculated.
Stool colitis score. A20myel-KO, A20IEC-KO, A20IEC/myel-KO and littermate wild-
type controls were scored for stool consistency and faecal blood loss using
Hemoccult-Sensa (Beckman Coulter Inc.). For bleeding, a score of 0 was assigned
for no blood, 2 for positive hemoccult and 4 for gross bleeding. For stool con-
sistency, a score of 0 was assigned for well-formed pellets; pasty and semiformed
stools were scored as 2 and liquid stools as 4. These scores were added together and
divided by 2, resulting in a clinical score ranging from 0 (healthy) to 4 (maximal
colitis). To eliminate any diagnostic bias, mice were scored blindly.
Endoscopic analysis. High-resolution mouse endoscopy and murine endoscopic
index of colitis severity (MEICS) scoring was performed, as previously described57,
using a ‘Coloview’ endoscopic system (Karl Storz, Tuttlingen, Germany). Mice were
anaesthetized with 2–2.5% isoflurane in oxygen during endoscopy.
Isolation of intestinal crypts and three-dimensional organoid culture. Intest-
inal organoids were derived from small intestine as previously described58. Briefly,
a 5 cm piece of duodenum/jejunum was dissected and washed in phosphate-
buffered saline (PBS). The intestine was opened longitudinally, villi were scraped
away and the tissue was chopped in 2–3mm pieces. After thorough washing in
PBS, pieces were incubated in 2mM EDTA/PBS for 30min at 4 C on a rocking
platform. After passage through a 70-mm cell strainer, crypt fractions were isolated
and purified by successive centrifugation steps. One ml of matrigel (BD
Biosciences) was added to a pellet of 100–1,000 crypts, and drops of 50 ml crypt-
containing matrigel were added to pre-warmed wells in a 24-well plate. After
polymerization, 500 ml complete growth medium containing EGF (Peprotech),
R-Spondin1 (R&D) and Noggin (Peprotech)59 was added to each well every 2 days.
For Wnt3a stimulation, growth medium was replaced with R-spondin-free medium
8 h before stimulation. A total of 200 ngml 1 Wnt3a (Peprotech) was added in
R-spondin containing growth medium for stimulation. For TNF and IFNg
stimulation (Escherichia coli-derived recombinant protein produced by VIB-
Protein service facility), 10 ngml 1 TNF or IFNg was diluted in organoid
growth medium.
Quantification of cytokines. Cytokines in serum were quantified by the Bio-plex
Pro kit (Bio-Rad) on the Bio-plex 200 system (Bio-rad).
Flow cytometry. Flow cytometric analysis was performed on a LSRII (BD Bios-
ciences). Cell suspensions were prepared from total spleens. Red blood cells were
lysed by incubation with ACK lysis buffer (BioWhittaker). Total cell suspensions
were pre-incubated with purified rat anti-mouse CD16/CD32 (mouse Fc block; BD
Biosciences, Pharmingen, 2.5 mgml 1), and splenocytes were incubated with anti-
CD11b-PerCpCy5.5 and anti-Gr1-FITC (BD Biosciences, both 1 mgml 1).
Tissue sample preparation. Freshly isolated colonic and ileal segments were
flushed with PBS to remove the faecal content and subsequently flushed with
formalin (4% formaldehyde in PBS and fixed by overnight incubation in a 10-fold
excess of formalin at 4 C. Formalin was removed and intestines were washed twice
with PBS before embedding in paraffin wax using standard methods.
Histology. Formalin fixed tissue was embedded in paraffin and 4 mm tissue sec-
tions were cut and stained with haematoxylin/eosin. For combined AB and PAS
stainings, dewaxed sections were hydrated and incubated in AB for 20min. Sec-
tions were subsequently washed with water before incubation in 1% periodic acid
for 10min followed by incubation in Schiff’s reagent for 10min. Sections were
counterstained with Mayer’s haematoxylin for 30 s, washed and dehydrated before
mounting with Pertex. For immunochemistry, sections were dewaxed and incu-
bated in Dako antigen retrieval solution and boiled for 20min in a Pick cell
cooking unit and cooled down for 2.5 h. Endogenous peroxidase activity was
blocked by immersing slides in peroxidase-blocking buffer (0.040M citric acid,
0.121M disodium hydrogen phosphate, 0.030M sodium azide, 1.5% hydrogen
peroxide) for 15min at room temperature. Blocking buffer (1% bovine serum
albumin in PBS) was added to the slides for 30min at room temperature. Primary
antibodies (mouse anti-b-catenin, 1/50 dilution, Transduction Lab; rabbit anti-Sox-
9, 1/600 dilution, Chemicon; mouse anti-Ki67, 1/100 dilution, Novocastra; rabbit
anti-lysozyme, 1/1,000 dilution, Dako; anti-Cleaved caspase-3, 1/1,000 dilution,
Cell Signaling; anti-CD45, 1/1,000 dilution, BD Pharmingen) were incubated
overnight in bovine serum albumin in PBS. Slides were then incubated with sec-
ondary antibody (polymer horseradish peroxidase-labelled anti-mouse/rabbit,
Envision) and peroxidase was detected by diaminobutyric acid (DAB) substrate.
Slides were counterstained with Mayer’s haematoxylin and mounted in Pertex
mounting medium. For lysozyme staining, sections were incubated with DyLight-
488 conjugated goat anti-rabbit secondary antibodies (1:1,000 dilution, Fisher
Bioblock Scientific), and cell nuclei were counterstained with DAPI (40,6-diami-
dino-2-phenylindole, Invitrogen) in ProLong Gold anti-fade reagent. Apoptosis
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was analyzed with an in situ cell death detection kit (TMR-red, Roche) after
antigen retrieval before incubation with the primary anti-lysozyme antibody for
combined TUNEL-lysozyme-DAPI staining. Fluorescence Microscopy was per-
formed using a TCS SP5 confocal microscope (Leica). Confocal images were
represented as frontal views of three-dimensional images (3D Opacity) or as three-
dimensional projections (Extended focus), using Volocity 5.5 imaging software
(PerkinElmer).
Quantification of cleaved caspase-3 positive cells. Ileal and colonic sections at
four different positions were analyzed per mouse, 10 consecutive crypts within each
section were analyzed for presence of cleaved caspase-3 positive cells and averages
per crypt are displayed.
In situ hybridization. The 4 mm-thick sections were rehydrated as described and
treated with 0.2M sodium chloride and proteinase K. Slides were post-fixed, and
sections were demethylated with acetic anhydride and prehybridized. Hybridiza-
tion was carried out in a humid chamber with 500 ngml 1 of freshly prepared
digoxigenin-labelled Olfm4 RNA probe (image clone 1078130) or Cryptidin-1
RNA probe (image clone 1096215) for at least 48 h at 68 C. Slides were then
washed and incubated with secondary anti-digoxigenin antibody (Roche) at 4 C
overnight, and developed using nitro blue tetrazolium chloride/5-bromo-4-chloro-
3-indolyl-phosphate.
Mucin immunostaining and bacterial FISH. Stainings were performed as
described10. Briefly, tissue was fixed in methanol-Carnoy (60% dry methanol, 30%
chloroform, 10% glacial acetic acid) solution overnight, and 4 mm paraffin sections
were processed for Mucin-2 immunohistochemistry (Santa Cruz, sc-15334, 1:200
dilution) and bacteria were detected with the universal bacterial FISH probe
EUB338 (50-GCTGCCTCCCGTAGGAGT-30), with 50Cy3 labelling.
Quantitative real-time PCR. Ileal segments of 5 cm long were freshly isolated and
flushed with PBS to remove the faecal content. One end was ligated and filled with
RNA lysis buffer (Aurum Total RNA Mini kit, Bio-Rad Laboratories) on ice for
5min. RNA was purified using the Aurum Total RNA Mini kit (Bio-Rad
Laboratories) and cDNA synthesis was performed using the iScript cDNA synth-
esis kit (Bio-Rad Laboratories) according to the manufacturer’s instructions. Ten
nanograms of cDNA was used for quantitative PCR in a total volume of 10 ml with
LightCycler 480 SYBR Green I Master Mix (Roche) on a LightCycler 480 (Roche).
Real-time PCR reactions were performed in triplicates. The following mouse-
specific primers were used: ubiquitin forward, 50-AGGTCAAACAGGAAGACAG
ACGTA-30 ; ubiquitin reverse, 50-TCACACCCAAGAACAAGCACA-30 ; lysozyme-
P forward, 50-gccaaggtctaacaatcgttgtgagttg-30 ; lysozyme-P reverse, 50-cagtcagccagct
tgacaccacg-30; cryptidin-1 forward, 50-tcaagaggctgcaaaggaagagaac-30 ; cryptidin-1
reverse, 50-tggtctccatgttcagcgacagc-30. Ascl-2 forward 50-CATGGAAGCACACCT
TGACTG-30 ; Ascl-2 reverse 50-CATCAAGCTTGCATTCAGCC-30 ; CD44 forward
50-TCTGCCATCTAGCACTAAGAGC-30 ; CD44 reverse 50-GTCTGGGTATTGA
AAGGTGTAGC-30 ; TnfRsF19 forward 50-ATTCTCTTCCTACTCCACCTG-30;
TnfRsF19 50-CATAGCCGAAGCCACATTC-30 ; Lgr5 forward 50-AGAACACTGA
CTTTGAATGG-30 ; Lgr5 reverse 50-GACAAATCTAGCACTTGGAG-30 ; Olfm4
forward 50-CGAAGTGGAGATAAGGAATATGAC-30 ; Olfm4 reverse 50-CCTCA
CATTCTTTCAGCTTGG-30 .
Electron microscopy. Intestinal tissue was washed twice for 30min in sodium
cacodylate buffer (0.1M pH 7.3, Sigma Genosys) embedded in agarose (Sigma
Genosys type VII, catalogue no. A-4018), and sectioned at 500mm and placed in
PBS. Tissue was dissected out and osmicated for 1 h at room temperature in 2%
OsO4 in sodium cacodylate buffer. Samples were dehydrated through a graded
ethanol series, followed by embedding in Spurr’s resin. Ultrathin sections of a gold
interference colour were cut using an ultramicrotome (Leica EM UC6), followed by
poststaining with uranyl acetate for 40min and for 7min in lead citrate in a Leica
EM AC20 and collected on formvar-coated copper slot grids. They were viewed
with a transmission electron microscope JEOL 1010 (JEOL, Tokyo, Japan).
In vivo TNF treatment. Mice were injected intraperitoneally with a sublethal dose
of mouse TNF (1 mg TNF per 20 g body weight). E. coli-derived recombinant
mTNF had a specific activity of 9.46 10E7 IUmg 1. Mouse TNF was produced
and purified to homogeneity in our laboratory, and endotoxin levels did not exceed
1 ngmg 1 of protein. Mice were euthanized after 4 h for histological analysis.
TNFAIP3 SNP and expression analysis in human IBD samples. TNFAIP3
genetic variants were evaluated in 2400 IBD patients from the IBD unit of the
University Hospital of Leuven (847 with UC and 1,553 with CD) and compared
with allele frequencies of 921 non-IBD controls. Both patients and controls were
genotyped through the immunochip platform. Allele frequencies were calculated
with the software package PLINK60 and the Cochran-Armitage trend test was used
to compare frequencies. Logistic regression analysis was performed to correct
associations for disease (UC or CD) and disease location (ileal, colonic or
ileocolonic). Genome-wide significance was determined as P¼ 5 10 8.
Haplotype analysis was performed with the software package Haploview61. Primary
non-response in those patients that received infliximab was assessed by
experienced clinicians and defined as no improvement of clinical symptoms after 2
or 3 infusions. A20 expression was investigated in endoscopically-derived intestinal
mucosal biopsies, as described by Arijs et al.27, from 61 active IBD patients naive to
infliximab therapy before and 4 to 6 weeks after their first infliximab infusion and
from 12 normal controls. Response was defined on the basis of endoscopic and
histologic findings. TNFAIP3 gene expression was analyzed by two probe sets
(202643_s_at and 202644_s_at) on the array.
Microbiota analysis. Total DNA was extracted from mice caecal content using the
QIAamp DNA stool Mini kit (Qiagen). DNA samples were amplified by 454/Roche
Titanium pyrosequencing of the V3–V5 16S RDNA region (BGI, Shenzhen). The
Qiime pipeline62 was used for open-reference OTU picking with (USEARCH v7)63,
obtaining a sample-wise OTU abundance matrix (630 OTU, 22 samples) with
Greengenes64 (version 13_5) taxonomic assignment. Statistical analyses were
performed in R (package phyloseq65). Variation partitioning and partialling out of
gender, age and cage-effects were performed by redundancy analysis (RDA).
Statistics. Results are expressed as the mean±s.e.m. Statistical significance
between experimental groups was assessed using the Wilcoxon signed-rank test
for paired samples and the using Student’s t-test or Mann–Whitney U-test for
unpaired samples.
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